In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Diversified Healthcare Trust (NASDAQ: DHC) was $2.12 for the day, up 1.92% from the previous closing price of $2.08. In other words, the price has increased by $1.92 from its previous closing price. On the day, 0.88 million shares were traded. DHC stock price reached its highest trading level at $2.13 during the session, while it also had its lowest trading level at $2.07.
Ratios:
Our analysis of DHC’s different ratios will help us gain a deeper understanding of the company. In the meantime, Its Debt-to-Equity ratio is 1.45 whereas as Long-Term Debt/Eq ratio is at 1.45.
Wells Fargo Downgraded its Overweight to Equal Weight on January 17, 2020, while the target price for the stock was maintained at $9.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 13 ’24 when Brown Matthew C. bought 2,000 shares for $2.55 per share. The transaction valued at 5,098 led to the insider holds 86,282 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DHC now has a Market Capitalization of 511502976 and an Enterprise Value of 3221521664. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.35 while its Price-to-Book (P/B) ratio in mrq is 0.25. Its current Enterprise Value per Revenue stands at 2.181 whereas that against EBITDA is 14.942.
Stock Price History:
The Beta on a monthly basis for DHC is 2.14, which has changed by -0.292517 over the last 52 weeks, in comparison to a change of 0.24440956 over the same period for the S&P500. Over the past 52 weeks, DHC has reached a high of $4.24, while it has fallen to a 52-week low of $2.01. The 50-Day Moving Average of the stock is -10.46%, while the 200-Day Moving Average is calculated to be -27.08%.
Shares Statistics:
DHC traded an average of 1.09M shares per day over the past three months and 855800 shares per day over the past ten days. A total of 241.28M shares are outstanding, with a floating share count of 216.23M. Insiders hold about 10.38% of the company’s shares, while institutions hold 75.06% stake in the company. Shares short for DHC as of 1735603200 were 7037380 with a Short Ratio of 6.44, compared to 1732838400 on 6810999. Therefore, it implies a Short% of Shares Outstanding of 7037380 and a Short% of Float of 3.2399999999999998.
Dividends & Splits
With its trailing 12-month dividend rate of 0.04, DHC has a forward annual dividend rate of 0.04. Against a Trailing Annual Dividend Yield of 0.01923077The stock’s 5-year Average Dividend Yield is 3.42.
Earnings Estimates
Investors are keenly observing as 1.0 analysts analyze and rate the current performance of Diversified Healthcare Trust (DHC) in the stock market.The consensus estimate for the next quarter is -$0.25, with high estimates of -$0.25 and low estimates of -$0.25.
Analysts are recommending an EPS of between -$1.47 and -$1.47 for the fiscal current year, implying an average EPS of -$1.47. EPS for the following year is -$0.92, with 1.0 analysts recommending between -$0.92 and -$0.92.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 2 analysts. It ranges from a high estimate of $374.3M to a low estimate of $367.64M. As of the current estimate, Diversified Healthcare Trust’s year-ago sales were $361.54MFor the next quarter, 2 analysts are estimating revenue of $374.17M. There is a high estimate of $394.5M for the next quarter, whereas the lowest estimate is $353.84M.
A total of 2 analysts have provided revenue estimates for DHC’s current fiscal year. The highest revenue estimate was $1.49B, while the lowest revenue estimate was $1.48B, resulting in an average revenue estimate of $1.49B. In the same quarter a year ago, actual revenue was $1.41BBased on 2 analysts’ estimates, the company’s revenue will be $1.55B in the next fiscal year. The high estimate is $1.67B and the low estimate is $1.43B.
